Figure 3From: Dynamics of soluble and cellular inflammatory markers in nasal lavage obtained from Cystic Fibrosis patients during intravenous antibiotic treatment Differences in inflammatory markers in healthy controls and CF patients, before and during i.v. antibiotic therapy. Matrixmetalloproteinase 9 (MMP9) was clearly attenuated during therapy (A). RANTES levels declined under AB treatment (B). IL-6 was found to be significantly elevated in CF (C), declining during antibiotic treatment in almost all CF patients (D).Back to article page